• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在循环免疫复合物中,高水平的氧化型 LDL 与 1 型糖尿病患者发生异常白蛋白尿的几率增加有关。

High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.

机构信息

Department of Medicine and Laboratory Services, Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, SC, USA.

出版信息

Nephrol Dial Transplant. 2012 Apr;27(4):1416-23. doi: 10.1093/ndt/gfr454. Epub 2011 Aug 19.

DOI:10.1093/ndt/gfr454
PMID:21856760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3471550/
Abstract

BACKGROUND

Modified low-density lipoprotein (LDL) immune complexes (IC) have proinflammatory properties and play a role in albuminuria development.

METHODS

We measured oxidized LDL (oxLDL) and advanced glycation end-product (AGE)-LDL in IC isolated from sera of Type 1 diabetic subjects followed for 14-20 years and studied their association with abnormal albuminuria. Patients with albumin excretion rates (AER)<40 mg/24 h at baseline and follow-up (n=302) were deemed resistant to developing abnormal albuminuria. Patients with AER<40 mg/24 h at baseline whose AER levels progressed to >40 mg/24 h were considered prone to abnormal albuminuria (n=185), those who progress to AER>299 mg/24 h were considered as having macroalbuminuria (n=57). The odds of developing abnormal albuminuria were estimated by logistic regression based on natural log-transformed levels of oxLDL and AGE-LDL in IC and stratified by baseline AER decile.

RESULTS

OxLDL and AGE-LDL were significantly higher in IC isolated from patients progressing to abnormal albuminuria. In unadjusted conditional logistic analysis, an increase of 1 SD in oxLDL and AGE-LDL levels in IC significantly increased the odds ratio (OR) for development of macroalbuminuria, respectively, by a factor of 2.5 and 1.8 (P<0.001, P=0.008). The increased odds of developing macroalbuminuria remained significant when adjusted for treatment group, diabetes duration, retinopathy, baseline hemoglobin A1c and LDL (OR=2.5 and 1.8, respectively, P<0.01).

CONCLUSION

Higher levels of oxLDL and AGE-LDL in circulating IC were associated with increased odds to develop abnormal albuminuria.

摘要

背景

修饰后的低密度脂蛋白(LDL)免疫复合物(IC)具有促炎作用,并在蛋白尿的发生发展中发挥作用。

方法

我们测量了在随访 14-20 年后从 1 型糖尿病患者血清中分离出的 IC 中的氧化 LDL(oxLDL)和晚期糖基化终产物(AGE)-LDL,并研究了它们与异常蛋白尿的关系。基线和随访时尿白蛋白排泄率(AER)<40mg/24h 的患者(n=302)被认为对发展异常蛋白尿有抵抗性。基线时 AER<40mg/24h 但 AER 水平进展至>40mg/24h 的患者被认为易发生异常白蛋白尿(n=185),进展至 AER>299mg/24h 的患者被认为患有大量白蛋白尿(n=57)。根据 oxLDL 和 AGE-LDL 在 IC 中的自然对数转换水平,并按基线 AER 十分位数分层,通过逻辑回归估计发展异常白蛋白尿的可能性。

结果

进展为异常白蛋白尿的患者 IC 中 oxLDL 和 AGE-LDL 明显升高。在未调整的条件逻辑分析中,IC 中 oxLDL 和 AGE-LDL 水平每增加 1 个标准差,发展为大量白蛋白尿的比值比(OR)分别增加 2.5 倍和 1.8 倍(P<0.001,P=0.008)。当调整治疗组、糖尿病病程、视网膜病变、基线血红蛋白 A1c 和 LDL 时,发展为大量白蛋白尿的可能性增加仍然显著(OR=2.5 和 1.8,P<0.01)。

结论

循环 IC 中 oxLDL 和 AGE-LDL 水平升高与发生异常白蛋白尿的几率增加相关。

相似文献

1
High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.在循环免疫复合物中,高水平的氧化型 LDL 与 1 型糖尿病患者发生异常白蛋白尿的几率增加有关。
Nephrol Dial Transplant. 2012 Apr;27(4):1416-23. doi: 10.1093/ndt/gfr454. Epub 2011 Aug 19.
2
Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.循环免疫复合物中氧化型 LDL 和晚期糖基化终产物修饰型 LDL 的水平与 1 型糖尿病患者颈动脉内膜中层厚度及其进展呈显著正相关。
Diabetes. 2011 Feb;60(2):582-9. doi: 10.2337/db10-0915. Epub 2010 Oct 27.
3
High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes.高水平的晚期糖基化终末产物修饰的低密度脂蛋白(AGE-LDL)以及与循环免疫复合物中氧化型低密度脂蛋白(oxLDL)和晚期糖基化终末产物修饰的低密度脂蛋白(MDA-LDL)所表达的丙二醛-赖氨酸表位发生反应的IgG抗体可预测2型糖尿病患者的大量白蛋白尿。
J Diabetes Complications. 2016 May-Jun;30(4):693-9. doi: 10.1016/j.jdiacomp.2016.01.012. Epub 2016 Jan 14.
4
High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.在循环免疫复合物中,高浓度的 AGE-LDL 和氧化型 LDL 与 1 型糖尿病视网膜病变的进展有关。
Diabetes Care. 2012 Jun;35(6):1333-40. doi: 10.2337/dc11-2040. Epub 2012 Apr 17.
5
Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy.氧化型低密度脂蛋白-抗氧化型低密度脂蛋白免疫复合物与糖尿病肾病
Diabetologia. 2002 Nov;45(11):1562-71. doi: 10.1007/s00125-002-0962-y. Epub 2002 Oct 12.
6
Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.循环免疫复合物中的氧化型 LDL 和 AGE-LDL 强烈预测 1 型糖尿病患者颈动脉 IMT 的进展。
Atherosclerosis. 2013 Dec;231(2):315-22. doi: 10.1016/j.atherosclerosis.2013.09.027. Epub 2013 Oct 11.
7
Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes.血浆中特定种类的超长链神经酰胺水平降低与 1 型糖尿病肾病的发生有关。
Metabolism. 2014 Oct;63(10):1287-95. doi: 10.1016/j.metabol.2014.07.001. Epub 2014 Jul 9.
8
Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.1 型糖尿病患者氧化型 LDL 免疫复合物与冠状动脉钙化。
Atherosclerosis. 2011 Feb;214(2):462-7. doi: 10.1016/j.atherosclerosis.2010.11.012. Epub 2010 Nov 17.
9
Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.氧化型低密度脂蛋白抗体和含低密度脂蛋白的免疫复合物作为糖尿病患者冠状动脉疾病的危险因素。
Clin Immunol. 1999 Feb;90(2):165-72. doi: 10.1006/clim.1998.4631.
10
The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.循环免疫复合物中 MDA-LDL 的水平可预测 VADT 研究中的心肌梗死。
Atherosclerosis. 2012 Oct;224(2):526-31. doi: 10.1016/j.atherosclerosis.2012.08.006. Epub 2012 Aug 21.

引用本文的文献

1
The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes.糖尿病前期和2型糖尿病患者中氧化型低密度脂蛋白(oxLDL)、可溶性凝集素样氧化型低密度脂蛋白受体-1(sLOX-1)、前蛋白转化酶枯草溶菌素9(PCSK9)与颈动脉内膜中层厚度的关系。
Sci Rep. 2025 Feb 7;15(1):4554. doi: 10.1038/s41598-025-89220-9.
2
GBP2 promotes M1 macrophage polarization by activating the notch1 signaling pathway in diabetic nephropathy.GBP2 通过激活 Notch1 信号通路促进糖尿病肾病中 M1 巨噬细胞极化。
Front Immunol. 2023 Aug 9;14:1127612. doi: 10.3389/fimmu.2023.1127612. eCollection 2023.
3
Integrated Analysis of Multiple Microarray Studies to Identify Core Gene-Expression Signatures Involved in Tubulointerstitial Injury in Diabetic Nephropathy.综合分析多个基因芯片研究鉴定糖尿病肾病小管间质性损伤相关的核心基因表达特征。
Biomed Res Int. 2022 May 10;2022:9554658. doi: 10.1155/2022/9554658. eCollection 2022.
4
Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study.氧化型 LDL 与蛋白尿性糖尿病肾病患者 eGFR 下降相关:一项队列研究。
Oxid Med Cell Longev. 2021 Oct 19;2021:2968869. doi: 10.1155/2021/2968869. eCollection 2021.
5
Oxidized LDL Modifies the Association between Proteinuria and Deterioration of Kidney Function in Proteinuric Diabetic Kidney Disease.氧化型低密度脂蛋白改变蛋白尿性糖尿病肾病中蛋白尿与肾功能恶化之间的关联。
Life (Basel). 2021 May 29;11(6):504. doi: 10.3390/life11060504.
6
Realising the long-term promise of insulin therapy: the DCCT/EDIC study.实现胰岛素治疗的长期承诺:DCCT/EDIC 研究。
Diabetologia. 2021 May;64(5):1049-1058. doi: 10.1007/s00125-021-05397-4. Epub 2021 Feb 6.
7
Weighted gene co-expression network analysis identifies as a key gene associated with diabetic kidney disease.加权基因共表达网络分析确定 为与糖尿病肾病相关的关键基因。 (注:原文中“identifies”后缺少具体内容)
Ann Transl Med. 2020 Nov;8(21):1427. doi: 10.21037/atm-20-1087.
8
Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.肾小球补体 C4c 沉积与 2 型糖尿病患者糖尿病肾病进展的相关性。
Front Immunol. 2020 Sep 2;11:2073. doi: 10.3389/fimmu.2020.02073. eCollection 2020.
9
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.靶向糖尿病肾病炎症的致病途径和治疗方法。
Int J Mol Sci. 2020 May 27;21(11):3798. doi: 10.3390/ijms21113798.
10
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.用于治疗糖尿病和慢性肾脏病患者的胰岛素及降糖药物。
Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD011798. doi: 10.1002/14651858.CD011798.pub2.

本文引用的文献

1
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.糖尿病控制与并发症试验/糖尿病干预和并发症流行病学研究队列中与炎症和内皮功能障碍相关的危险因素及其与肾病和大血管并发症的关系。
Diabetes Care. 2008 Oct;31(10):2006-12. doi: 10.2337/dc08-0659. Epub 2008 Jul 15.
2
Oxidative stress as a major culprit in kidney disease in diabetes.氧化应激是糖尿病肾病的主要元凶。
Diabetes. 2008 Jun;57(6):1446-54. doi: 10.2337/db08-0057.
3
Clinical review: The role of advanced glycation end products in progression and complications of diabetes.临床综述:晚期糖基化终末产物在糖尿病进展及并发症中的作用
J Clin Endocrinol Metab. 2008 Apr;93(4):1143-52. doi: 10.1210/jc.2007-1817. Epub 2008 Jan 8.
4
AGE, RAGE, and ROS in diabetic nephropathy.糖尿病肾病中的年龄、晚期糖基化终末产物及其受体和活性氧
Semin Nephrol. 2007 Mar;27(2):130-43. doi: 10.1016/j.semnephrol.2007.01.006.
5
Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study.血清白细胞介素-18水平升高对2型糖尿病早期肾功能不全的预测作用:一项观察性随访研究
Diabetologia. 2007 Apr;50(4):867-73. doi: 10.1007/s00125-006-0586-8. Epub 2007 Jan 16.
6
Advanced glycation end products: sparking the development of diabetic vascular injury.晚期糖基化终末产物:引发糖尿病血管损伤的发展
Circulation. 2006 Aug 8;114(6):597-605. doi: 10.1161/CIRCULATIONAHA.106.621854.
7
Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.含有修饰脂蛋白的免疫复合物与1型糖尿病患者颈内动脉内膜中层厚度的进展有关。
Atherosclerosis. 2007 Feb;190(2):359-69. doi: 10.1016/j.atherosclerosis.2006.02.007. Epub 2006 Mar 10.
8
Inflammation and dyslipidemia in nephropathy: an epidemiologic perspective.肾病中的炎症与血脂异常:流行病学视角
Kidney Int. 2006 Jan;69(2):206-8. doi: 10.1038/sj.ki.5000111.
9
Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort.1型糖尿病患者显性肾病的新型预测指标。一项来自匹兹堡糖尿病并发症流行病学队列的巢式病例对照研究。
Nephrol Dial Transplant. 2006 Jan;21(1):93-100. doi: 10.1093/ndt/gfi103. Epub 2005 Sep 6.
10
Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.2型糖尿病患者炎症及肾小球结构的急性期标志物
J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S78-82. doi: 10.1681/asn.2004110961.